State of Wisconsin Investment Board
FSTX

State of Wisconsin Investment Board’s F-star Therapeutics, Inc. Common Stock FSTX Stock Holding History

State of Wisconsin Investment Board’s Portfolio FSTX Stock Details FSTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-4,725
Closed -$198K – 1624
2019
Q1 		$198K Buy
4,725
+1,100
+30% +$46.3K ﹤0.01% 1463
2018
Q4 		$151K Buy
+3,625
New +$163K ﹤0.01% 1472

Other funds holding FSTX

Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TA
Tiedemann Advisors New York $2.33B AUM 15.56% 1-Year Est. Return
Axa
Axa Paris, France $256M AUM 25.01% 1-Year Est. Return
PCM
Parsons Capital Management Providence, Rhode Island $2.21B AUM 28.12% 1-Year Est. Return
SAM
Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State of Wisconsin Investment Board's FSTX Position: Q2 2019 in Review

State of Wisconsin Investment Board sold out of F-star Therapeutics, Inc. Common Stock (FSTX) in Q2 2019, closing a stake of 4,725 shares — an estimated $198K sold.

State of Wisconsin Investment Board first reported a position in FSTX in Q4 2018 and held it in 2 quarters. The position peaked at $198K in Q1 2019. 50 funds tracked by Wall St. Rank hold FSTX as of Q2 2019.

  • State of Wisconsin Investment Board reported no remaining F-star Therapeutics, Inc. Common Stock position as of Q2 2019 after selling out during the quarter.
  • State of Wisconsin Investment Board sold 4,725 F-star Therapeutics, Inc. Common Stock shares in Q2 2019, an estimated $198K.
  • State of Wisconsin Investment Board first reported a position in F-star Therapeutics, Inc. Common Stock in Q4 2018 and held it in 2 quarters.
  • State of Wisconsin Investment Board's F-star Therapeutics, Inc. Common Stock position peaked at $198K in Q1 2019.
  • 50 funds tracked by Wall St. Rank held F-star Therapeutics, Inc. Common Stock as of Q2 2019.

Based on State of Wisconsin Investment Board's 13F filing for Q2 2019, filed 14 Aug 2019.